Literature DB >> 11689158

Neuronal nuclear alterations in dentatorubral-pallidoluysian atrophy: ultrastructural and morphometric studies of the cerebellar granule cells.

H Takahashi1, S Egawa, Y S Piao, S Hayashi, M Yamada, T Shimohata, K Oyanagi, S Tsuji.   

Abstract

Dentatorubral-pallidoluysian atrophy (DRPLA) is an autosomal dominant neurodegenerative disease caused by a CAG repeat expansion, resulting in ubiquitinated inclusions and diffuse accumulation of mutant atrophin-1 in the neuronal nuclei in many regions of the central nervous system. In the cerebellar cortex, such nuclear abnormalities occur in the granule cells. In the present study, we performed ultrastructural and morphometric analyses on the nuclei of the cerebellar granule cells from eight patients with DRPLA (four with juvenile-onset disease and four with adult-onset disease) in an attempt to obtain further insight into the neuronal nuclear alterations that occur in CAG-repeat diseases. Ultrastructurally, all patients had intranuclear filamentous inclusions (NIIs, neuronal intranuclear inclusions) and nuclear membrane indentations (NMIs) in some of their granule cells, and chromatin tended to be sparse in the nucleoplasm of the affected nuclei. No such changes were observed in the granule cells of four control subjects. In all patients there was an association between NIIs and NMIs, and nuclei with NIIs and/or NMIs were larger than those without such changes. However, the nuclear enlargement was not due solely to the NIIs - even nuclei without NIIs or NMIs were larger in the patients than in the controls. In the DRPLA patients, there was a significant inverse correlation between the cross-sectional area of the nuclei and the disease duration. These findings indicate that NIIs and NMIs are features in the disease and occur in association with each other, and that nuclear enlargement - the degree of which may decrease with time after onset of the illness - is a more prevalent abnormality than the formation of NIIs or NMIs.

Entities:  

Mesh:

Year:  2001        PMID: 11689158     DOI: 10.1016/s0006-8993(01)02986-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Repeat-associated non-ATG (RAN) translation.

Authors:  John Douglas Cleary; Amrutha Pattamatta; Laura P W Ranum
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

Review 2.  Non-apoptotic cell death in animal development.

Authors:  Lena M Kutscher; Shai Shaham
Journal:  Cell Death Differ       Date:  2017-02-17       Impact factor: 15.828

Review 3.  PolyQ disease: misfiring of a developmental cell death program?

Authors:  Elyse S Blum; Andrew R Schwendeman; Shai Shaham
Journal:  Trends Cell Biol       Date:  2012-12-08       Impact factor: 20.808

Review 4.  Nuclear transport, oxidative stress, and neurodegeneration.

Authors:  Vivek P Patel; Charleen T Chu
Journal:  Int J Clin Exp Pathol       Date:  2011-02-28

Review 5.  New developments in RAN translation: insights from multiple diseases.

Authors:  John Douglas Cleary; Laura Pw Ranum
Journal:  Curr Opin Genet Dev       Date:  2017-03-30       Impact factor: 5.578

6.  Attenuated nuclear shrinkage in neurones with nuclear inclusions of SCA1 brains.

Authors:  U Nagaoka; T Uchihara; K Iwabuchi; H Konno; M Tobita; N Funata; S Yagishita; T Kato
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

7.  Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.

Authors:  Kathryn McFadden; Ronald L Hamilton; Sam J Insalaco; Lawrence Lavine; Majeed Al-Mateen; Guoji Wang; Clayton A Wiley
Journal:  J Neuropathol Exp Neurol       Date:  2005-06       Impact factor: 3.685

8.  Distribution and pattern of pathology in subjects with familial or sporadic late-onset cerebellar ataxia as assessed by p62/sequestosome immunohistochemistry.

Authors:  Maria Pikkarainen; Päivi Hartikainen; Hilkka Soininen; Irina Alafuzoff
Journal:  Cerebellum       Date:  2011-12       Impact factor: 3.847

9.  Huntington's disease is a four-repeat tauopathy with tau nuclear rods.

Authors:  Marta Fernández-Nogales; Jorge R Cabrera; María Santos-Galindo; Jeroen J M Hoozemans; Isidro Ferrer; Annemieke J M Rozemuller; Félix Hernández; Jesús Avila; José J Lucas
Journal:  Nat Med       Date:  2014-07-20       Impact factor: 53.440

Review 10.  The expanding role for chromatin and transcription in polyglutamine disease.

Authors:  Ryan D Mohan; Susan M Abmayr; Jerry L Workman
Journal:  Curr Opin Genet Dev       Date:  2014-08-11       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.